Effect of vitamin E on lipid peroxidation and liver monooxigenase activity in experimental influenza virus infection.
Identifieur interne : 000A18 ( PubMed/Curation ); précédent : 000A17; suivant : 000A19Effect of vitamin E on lipid peroxidation and liver monooxigenase activity in experimental influenza virus infection.
Auteurs : M. Mileva [Bulgarie] ; L. Tancheva ; R. Bakalova ; A. Galabov ; V. Savov ; S. RibarovSource :
- Toxicology letters [ 0378-4274 ] ; 2000.
Descripteurs français
- KwdFr :
- Aminopyrine N-demethylase (antagonistes et inhibiteurs), Aminopyrine N-demethylase (métabolisme), Aniline hydroxylase (antagonistes et inhibiteurs), Aniline hydroxylase (métabolisme), Animaux, Cytochrome P-450 enzyme system (métabolisme), Ethylmorphine-N-demethylase (antagonistes et inhibiteurs), Ethylmorphine-N-demethylase (métabolisme), Foie (), Foie (enzymologie), Foie (virologie), Infections à Orthomyxoviridae (enzymologie), Infections à Orthomyxoviridae (traitement médicamenteux), Inhibiteurs des enzymes du cytochrome P-450, Mâle, Métamizole sodique (métabolisme), NADPH-ferrihemoprotéine reductase (métabolisme), Peroxydation lipidique (), Relation dose-effet des médicaments, Souris, Stress oxydatif (), Substances réactives à l'acide thiobarbiturique (métabolisme), Virus de la grippe A (métabolisme), Vitamine E (pharmacologie).
- MESH :
- antagonistes et inhibiteurs : Aminopyrine N-demethylase, Aniline hydroxylase, Ethylmorphine-N-demethylase.
- enzymologie : Foie, Infections à Orthomyxoviridae.
- métabolisme : Aminopyrine N-demethylase, Aniline hydroxylase, Cytochrome P-450 enzyme system, Ethylmorphine-N-demethylase, Métamizole sodique, NADPH-ferrihemoprotéine reductase, Substances réactives à l'acide thiobarbiturique, Virus de la grippe A.
- pharmacologie : Vitamine E.
- traitement médicamenteux : Infections à Orthomyxoviridae.
- virologie : Foie.
- Animaux, Foie, Inhibiteurs des enzymes du cytochrome P-450, Mâle, Peroxydation lipidique, Relation dose-effet des médicaments, Souris, Stress oxydatif.
English descriptors
- KwdEn :
- Aminopyrine N-Demethylase (antagonists & inhibitors), Aminopyrine N-Demethylase (metabolism), Aniline Hydroxylase (antagonists & inhibitors), Aniline Hydroxylase (metabolism), Animals, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Enzyme System (metabolism), Dipyrone (metabolism), Dose-Response Relationship, Drug, Ethylmorphine-N-Demethylase (antagonists & inhibitors), Ethylmorphine-N-Demethylase (metabolism), Influenza A virus (metabolism), Lipid Peroxidation (drug effects), Liver (drug effects), Liver (enzymology), Liver (virology), Male, Mice, NADPH-Ferrihemoprotein Reductase (metabolism), Orthomyxoviridae Infections (drug therapy), Orthomyxoviridae Infections (enzymology), Oxidative Stress (drug effects), Thiobarbituric Acid Reactive Substances (metabolism), Vitamin E (pharmacology).
- MESH :
- chemical , antagonists & inhibitors : Aminopyrine N-Demethylase, Aniline Hydroxylase, Ethylmorphine-N-Demethylase.
- chemical , metabolism : Aminopyrine N-Demethylase, Aniline Hydroxylase, Cytochrome P-450 Enzyme System, Dipyrone, Ethylmorphine-N-Demethylase, NADPH-Ferrihemoprotein Reductase, Thiobarbituric Acid Reactive Substances.
- drug effects : Lipid Peroxidation, Liver, Oxidative Stress.
- drug therapy : Orthomyxoviridae Infections.
- enzymology : Liver, Orthomyxoviridae Infections.
- metabolism : Influenza A virus.
- chemical , pharmacology : Vitamin E.
- virology : Liver.
- Animals, Cytochrome P-450 Enzyme Inhibitors, Dose-Response Relationship, Drug, Male, Mice.
Abstract
Influenza virus infection was associated with development of oxidative stress in liver of mice, viz. increase in amount of lipid peroxidation products, decrease in cytochrome P-450 and NADP. H-cytochrome c-reductase activity, and inhibition of liver monooxygenases (aniline hydroxylase, ethylmorphine-N-demethylase, amidopyrine-N-demethylase and analgin-N-demethylase). These effects were most pronounced on the 7th day after virus inoculation as compared to the 5th one. Supplementation of mice with vitamin E before virus inoculation leads to liver protection against oxidative stress and toxicosis. A marked decrease of lipid peroxidation products and an increase of cytochrome P-450 and activities of monooxygenases was established. The stabilizing effect of vitamin E was dose-dependent and was most pronounced on the 5th day after virus inoculation as compared to the 7th one.
DOI: 10.1016/s0378-4274(99)00265-9
PubMed: 10713467
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000A21
Links to Exploration step
pubmed:10713467Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Effect of vitamin E on lipid peroxidation and liver monooxigenase activity in experimental influenza virus infection.</title><author><name sortKey="Mileva, M" sort="Mileva, M" uniqKey="Mileva M" first="M" last="Mileva">M. Mileva</name><affiliation wicri:level="1"><nlm:affiliation>Department of Medical Physics and Biophysics, Medical University, 2 Zdrave Str., Sofia, Bulgaria.</nlm:affiliation><country xml:lang="fr">Bulgarie</country><wicri:regionArea>Department of Medical Physics and Biophysics, Medical University, 2 Zdrave Str., Sofia</wicri:regionArea></affiliation></author><author><name sortKey="Tancheva, L" sort="Tancheva, L" uniqKey="Tancheva L" first="L" last="Tancheva">L. Tancheva</name></author><author><name sortKey="Bakalova, R" sort="Bakalova, R" uniqKey="Bakalova R" first="R" last="Bakalova">R. Bakalova</name></author><author><name sortKey="Galabov, A" sort="Galabov, A" uniqKey="Galabov A" first="A" last="Galabov">A. Galabov</name></author><author><name sortKey="Savov, V" sort="Savov, V" uniqKey="Savov V" first="V" last="Savov">V. Savov</name></author><author><name sortKey="Ribarov, S" sort="Ribarov, S" uniqKey="Ribarov S" first="S" last="Ribarov">S. Ribarov</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2000">2000</date><idno type="RBID">pubmed:10713467</idno><idno type="pmid">10713467</idno><idno type="doi">10.1016/s0378-4274(99)00265-9</idno><idno type="wicri:Area/PubMed/Corpus">000A21</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000A21</idno><idno type="wicri:Area/PubMed/Curation">000A18</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000A18</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Effect of vitamin E on lipid peroxidation and liver monooxigenase activity in experimental influenza virus infection.</title><author><name sortKey="Mileva, M" sort="Mileva, M" uniqKey="Mileva M" first="M" last="Mileva">M. Mileva</name><affiliation wicri:level="1"><nlm:affiliation>Department of Medical Physics and Biophysics, Medical University, 2 Zdrave Str., Sofia, Bulgaria.</nlm:affiliation><country xml:lang="fr">Bulgarie</country><wicri:regionArea>Department of Medical Physics and Biophysics, Medical University, 2 Zdrave Str., Sofia</wicri:regionArea></affiliation></author><author><name sortKey="Tancheva, L" sort="Tancheva, L" uniqKey="Tancheva L" first="L" last="Tancheva">L. Tancheva</name></author><author><name sortKey="Bakalova, R" sort="Bakalova, R" uniqKey="Bakalova R" first="R" last="Bakalova">R. Bakalova</name></author><author><name sortKey="Galabov, A" sort="Galabov, A" uniqKey="Galabov A" first="A" last="Galabov">A. Galabov</name></author><author><name sortKey="Savov, V" sort="Savov, V" uniqKey="Savov V" first="V" last="Savov">V. Savov</name></author><author><name sortKey="Ribarov, S" sort="Ribarov, S" uniqKey="Ribarov S" first="S" last="Ribarov">S. Ribarov</name></author></analytic><series><title level="j">Toxicology letters</title><idno type="ISSN">0378-4274</idno><imprint><date when="2000" type="published">2000</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aminopyrine N-Demethylase (antagonists & inhibitors)</term><term>Aminopyrine N-Demethylase (metabolism)</term><term>Aniline Hydroxylase (antagonists & inhibitors)</term><term>Aniline Hydroxylase (metabolism)</term><term>Animals</term><term>Cytochrome P-450 Enzyme Inhibitors</term><term>Cytochrome P-450 Enzyme System (metabolism)</term><term>Dipyrone (metabolism)</term><term>Dose-Response Relationship, Drug</term><term>Ethylmorphine-N-Demethylase (antagonists & inhibitors)</term><term>Ethylmorphine-N-Demethylase (metabolism)</term><term>Influenza A virus (metabolism)</term><term>Lipid Peroxidation (drug effects)</term><term>Liver (drug effects)</term><term>Liver (enzymology)</term><term>Liver (virology)</term><term>Male</term><term>Mice</term><term>NADPH-Ferrihemoprotein Reductase (metabolism)</term><term>Orthomyxoviridae Infections (drug therapy)</term><term>Orthomyxoviridae Infections (enzymology)</term><term>Oxidative Stress (drug effects)</term><term>Thiobarbituric Acid Reactive Substances (metabolism)</term><term>Vitamin E (pharmacology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Aminopyrine N-demethylase (antagonistes et inhibiteurs)</term><term>Aminopyrine N-demethylase (métabolisme)</term><term>Aniline hydroxylase (antagonistes et inhibiteurs)</term><term>Aniline hydroxylase (métabolisme)</term><term>Animaux</term><term>Cytochrome P-450 enzyme system (métabolisme)</term><term>Ethylmorphine-N-demethylase (antagonistes et inhibiteurs)</term><term>Ethylmorphine-N-demethylase (métabolisme)</term><term>Foie ()</term><term>Foie (enzymologie)</term><term>Foie (virologie)</term><term>Infections à Orthomyxoviridae (enzymologie)</term><term>Infections à Orthomyxoviridae (traitement médicamenteux)</term><term>Inhibiteurs des enzymes du cytochrome P-450</term><term>Mâle</term><term>Métamizole sodique (métabolisme)</term><term>NADPH-ferrihemoprotéine reductase (métabolisme)</term><term>Peroxydation lipidique ()</term><term>Relation dose-effet des médicaments</term><term>Souris</term><term>Stress oxydatif ()</term><term>Substances réactives à l'acide thiobarbiturique (métabolisme)</term><term>Virus de la grippe A (métabolisme)</term><term>Vitamine E (pharmacologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Aminopyrine N-Demethylase</term><term>Aniline Hydroxylase</term><term>Ethylmorphine-N-Demethylase</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Aminopyrine N-Demethylase</term><term>Aniline Hydroxylase</term><term>Cytochrome P-450 Enzyme System</term><term>Dipyrone</term><term>Ethylmorphine-N-Demethylase</term><term>NADPH-Ferrihemoprotein Reductase</term><term>Thiobarbituric Acid Reactive Substances</term></keywords><keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr"><term>Aminopyrine N-demethylase</term><term>Aniline hydroxylase</term><term>Ethylmorphine-N-demethylase</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Lipid Peroxidation</term><term>Liver</term><term>Oxidative Stress</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Orthomyxoviridae Infections</term></keywords><keywords scheme="MESH" qualifier="enzymologie" xml:lang="fr"><term>Foie</term><term>Infections à Orthomyxoviridae</term></keywords><keywords scheme="MESH" qualifier="enzymology" xml:lang="en"><term>Liver</term><term>Orthomyxoviridae Infections</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Influenza A virus</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Aminopyrine N-demethylase</term><term>Aniline hydroxylase</term><term>Cytochrome P-450 enzyme system</term><term>Ethylmorphine-N-demethylase</term><term>Métamizole sodique</term><term>NADPH-ferrihemoprotéine reductase</term><term>Substances réactives à l'acide thiobarbiturique</term><term>Virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Vitamine E</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Vitamin E</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à Orthomyxoviridae</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Foie</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Liver</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Cytochrome P-450 Enzyme Inhibitors</term><term>Dose-Response Relationship, Drug</term><term>Male</term><term>Mice</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Foie</term><term>Inhibiteurs des enzymes du cytochrome P-450</term><term>Mâle</term><term>Peroxydation lipidique</term><term>Relation dose-effet des médicaments</term><term>Souris</term><term>Stress oxydatif</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Influenza virus infection was associated with development of oxidative stress in liver of mice, viz. increase in amount of lipid peroxidation products, decrease in cytochrome P-450 and NADP. H-cytochrome c-reductase activity, and inhibition of liver monooxygenases (aniline hydroxylase, ethylmorphine-N-demethylase, amidopyrine-N-demethylase and analgin-N-demethylase). These effects were most pronounced on the 7th day after virus inoculation as compared to the 5th one. Supplementation of mice with vitamin E before virus inoculation leads to liver protection against oxidative stress and toxicosis. A marked decrease of lipid peroxidation products and an increase of cytochrome P-450 and activities of monooxygenases was established. The stabilizing effect of vitamin E was dose-dependent and was most pronounced on the 5th day after virus inoculation as compared to the 7th one.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">10713467</PMID><DateCompleted><Year>2000</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0378-4274</ISSN><JournalIssue CitedMedium="Print"><Volume>114</Volume><Issue>1-3</Issue><PubDate><Year>2000</Year><Month>Apr</Month><Day>03</Day></PubDate></JournalIssue><Title>Toxicology letters</Title><ISOAbbreviation>Toxicol. Lett.</ISOAbbreviation></Journal><ArticleTitle>Effect of vitamin E on lipid peroxidation and liver monooxigenase activity in experimental influenza virus infection.</ArticleTitle><Pagination><MedlinePgn>39-45</MedlinePgn></Pagination><Abstract><AbstractText>Influenza virus infection was associated with development of oxidative stress in liver of mice, viz. increase in amount of lipid peroxidation products, decrease in cytochrome P-450 and NADP. H-cytochrome c-reductase activity, and inhibition of liver monooxygenases (aniline hydroxylase, ethylmorphine-N-demethylase, amidopyrine-N-demethylase and analgin-N-demethylase). These effects were most pronounced on the 7th day after virus inoculation as compared to the 5th one. Supplementation of mice with vitamin E before virus inoculation leads to liver protection against oxidative stress and toxicosis. A marked decrease of lipid peroxidation products and an increase of cytochrome P-450 and activities of monooxygenases was established. The stabilizing effect of vitamin E was dose-dependent and was most pronounced on the 5th day after virus inoculation as compared to the 7th one.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mileva</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Physics and Biophysics, Medical University, 2 Zdrave Str., Sofia, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tancheva</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Bakalova</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Galabov</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Savov</LastName><ForeName>V</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Ribarov</LastName><ForeName>S</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Toxicol Lett</MedlineTA><NlmUniqueID>7709027</NlmUniqueID><ISSNLinking>0378-4274</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D065607">Cytochrome P-450 Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017392">Thiobarbituric Acid Reactive Substances</NameOfSubstance></Chemical><Chemical><RegistryNumber>1406-18-4</RegistryNumber><NameOfSubstance UI="D014810">Vitamin E</NameOfSubstance></Chemical><Chemical><RegistryNumber>6429L0L52Y</RegistryNumber><NameOfSubstance UI="D004177">Dipyrone</NameOfSubstance></Chemical><Chemical><RegistryNumber>9035-51-2</RegistryNumber><NameOfSubstance UI="D003577">Cytochrome P-450 Enzyme System</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.14.-</RegistryNumber><NameOfSubstance UI="D000815">Aniline Hydroxylase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.5.3.-</RegistryNumber><NameOfSubstance UI="D000633">Aminopyrine N-Demethylase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.5.3.-</RegistryNumber><NameOfSubstance UI="D005037">Ethylmorphine-N-Demethylase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.5.3.-</RegistryNumber><NameOfSubstance UI="C019666">amidopyrine N-demethylase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.6.2.4</RegistryNumber><NameOfSubstance UI="D009251">NADPH-Ferrihemoprotein Reductase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000633" MajorTopicYN="N">Aminopyrine N-Demethylase</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000815" MajorTopicYN="N">Aniline Hydroxylase</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065607" MajorTopicYN="N">Cytochrome P-450 Enzyme Inhibitors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003577" MajorTopicYN="N">Cytochrome P-450 Enzyme System</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004177" MajorTopicYN="N">Dipyrone</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005037" MajorTopicYN="N">Ethylmorphine-N-Demethylase</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009980" MajorTopicYN="N">Influenza A virus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015227" MajorTopicYN="N">Lipid Peroxidation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009251" MajorTopicYN="N">NADPH-Ferrihemoprotein Reductase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009976" MajorTopicYN="N">Orthomyxoviridae Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017392" MajorTopicYN="N">Thiobarbituric Acid Reactive Substances</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014810" MajorTopicYN="N">Vitamin E</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2000</Year><Month>3</Month><Day>14</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2000</Year><Month>5</Month><Day>8</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2000</Year><Month>3</Month><Day>14</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">10713467</ArticleId><ArticleId IdType="pii">S0378427499002659</ArticleId><ArticleId IdType="doi">10.1016/s0378-4274(99)00265-9</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A18 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000A18 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= StressCovidV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:10713467
|texte= Effect of vitamin E on lipid peroxidation and liver monooxigenase activity in experimental influenza virus infection.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:10713467" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a StressCovidV1
| This area was generated with Dilib version V0.6.33. |  |